News

I have been living with stage 4 lung cancer for almost 10 years now. Planning out my life 3-4 months at a time is a regular thing for me. Many...

There is a new opportunity to participate in a research study about health literacy. Health Literacy Media shares more. We are Health Literacy Media, a non-profit organization based in St...

The United States Preventive Services Task Force (USPSTF) has issued 2021 guidelines for lung cancer screening. The last change made to these guidelines was in 2013. A screening test is...

The U.S. Food and Drug Administration (FDA) has approved Coselsa (trilaciclib) to protect bone marrow from damage caused by chemotherapy. Coselsa is approved for use in adults receiving certain types...

The American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the...

The U.S. Food and Drug Administration (FDA) has granted a new indication (use) for Tagrisso® (osimertinib). The latest indication is for adjuvant therapy after tumor resection (removal) in people with...

The United States Food and Drug Administration (US FDA) has approved Zepzelca for the treatment of small cell lung cancer (SCLC). Zepzelca (lurbinectedin) is specifically used for adults whose cancer...

The United States Food and Drug Administration (US FDA) has expanded the use of Tecentriq for non-small cell lung cancer (NSCLC). Tecentriq (atezolizumab) has been approved in the past for...

The United States Food and Drug Administration (US FDA) has approved the use of Opdivo (nivolumab) and Yervoy (ipilimumab) together for non-small cell lung cancer (NSCLC). Opdivo (nivolumab) and Yervoy...

Lung cancer is the second most common cancer in both men and women accounting for 13 percent of all new cancers. Approximately 15 percent of all lung cancers are small...

The United States Food and Drug Administration (US FDA) has approved the drug Imfinzi (durvalumab) for small-cell lung cancer. Imfinzi is specifically for people with small-cell lung cancer that has...

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for JNJ-6372 to Janssen Pharmaceutical, a Johnson & Johnson Company. NJ-6372 is an investigational treatment for metastatic non-small...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

In its Lung Cancer Scorecard, LUNGevity Foundation grades each state on its access to care and lung cancer statistics. Based on their analysis, over half of the states receive a...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...

People with lung cancer are living longer. This is a key finding of The State of Lung Cancer 2019 report issued by the American Lung Association. The survival rate for...

The American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017...

Hillstream BioPharma announced that it has been granted FDA orphan drug designation (ODD) for HSB-1216 for the treatment of small cell lung cancer (SCLC).1-2 QUATRAMER salinomycin is a new formulation...